This year, more than ever, has underscored the critical services that biobanks provide to biomedical researchers and other scientists. By implementing a regulatory-compliant, configurable Laboratory Information Management System (LIMS), biobanks can follow best practice guidelines and overcome logistical, regulatory and safety challenges. This guide takes a look at how biobanks can choose the best LIMS to suit their operations.

Liquid chromatography has proven to be an invaluable tool in analytical labs. However, despite being a “mature” technique, there are still some areas that prove problematic, leading to suboptimal results. One such area is the loss of analytes during the chromatographic process, but design innovations are aiming to overcome this problem.

Leveraging patient-generated health data (PGHD) in healthcare and clinical trials has become significantly easier with the advent of digitalization. We spoke to Alison Bourke, scientific director for real world insights at IQVIA and past president of the International Society for Pharmacoepidemiology, about how PGHD is collected, why it is useful and how we can best safeguard sensitive data.

2020 was an important year for proteomics. The COVID-19 global pandemic cast a spotlight on the field's clinical utility in the fight against a public health crisis, from which there are many lessons to be drawn that will undoubtedly influence the landscape of the field for years to come. Technology Networks spoke with Rohan Thakur, executive vice president of Life Sciences Mass Spectrometry at Bruker Daltonics, to discuss the current state-of-play in proteomics.

Technology Networks spoke with Pierre-Louis Joffrin, corporate development officer at Mogrify, to learn more about the EpiMOGRIFY platform, the advantages of using a data-driven method to maintain cell identity and support cell conversion, and the implications this could have for the development of cell therapies.

Liquid chromatography (LC) is an essential technique is many analytical labs. Dr Bob Pirok and his team use informatics techniques to make LC more automated and pain-free. Technology Networks recently spoke to Pirok to find out more about his innovative algorithms.

Single-cell technologies have positioned themselves at the forefront of biomedical research. But the value of these systems risks being impaired by bottlenecks in data analysis and handling. To find out more, we spoke to Marilyn Matz, CEO and co-founder of Paradigm4.

Genomic data company PetaGene recently sounded a warning that Genome UK, the UK government’s recently announced genomic healthcare strategy, needs to address important data handling challenges to maintain public trust. To find out more, Technology Networks spoke to PetaGene’s co-founder and chief commercial officer, Vaughan Wittorff, PhD, and co-founder and chief executive officer, Dan Greenfield, PhD.

Emerging technologies have the potential to significantly transform the laboratory environment. In this Insight, Labforward's Phoebe Chubb outlines what the lab of the future will look like.

Data integrity is fundamental to drug development and manufacturing but can be difficult to achieve for drug developers and manufacturers who have to navigate strict data integrity guidelines provided by regulatory authorities and find effective ways to attain compliance.